Gabapentin, 60142-96-3, Levetiracetam, 102767-28-2, Sodium Loxoprofen, 80382-23-6, Intermediate
| Post Date: |
2008-10-01 16:16:01.0 |
| Expiry Date: |
2009-10-01 |
|
| Date Joined: |
2008-09-08 13:53:31.0 |
| SignIn: |
0 |
| Year Established: |
|
| Number of R&D Staff: |
|
| Registered Capital: |
|
 |
|
|
|
Detailed Selling Lead Description
Gabapentin Intermediates
1,1-Cyclohexanediacetic acid (CDA), 4355-11-7, Gabapentin Intermediate
1,1- Cyclohexanediacetic acid,mono amide (CAM), 99189-60-3, Gabapentin Intermediate
3,3-Pentamethylene-4-butyrolactam (CDI), 64744-50-9, Gabapentin Intermediate
Levetiracetam Intermediates
alpha-Ethyl-2-oxo-1-Pyrrolidineacetic acid (LVA20), 67118-31-4, Levetiracetam Intermediate
(S)-alpha-Ethyl-2-oxo-1-Pyrrolidineacetic acid, (R)-methylbenzylamine salt (LVA30), 102916-46-1, Levetiracetam Intermediate
(S)-alpha-Ethyl-2-oxo-1-Pyrrolidineacetic acid (LVA40), 102849-49-0, Levetiracetam Intermediate
Sodium Loxoprofen Intermediates
2-p-Tolylpropanoic acid (MPA), 938-94-3, Sodium Loxoprofen Intermediate
Ethyl 2-oxocyclopentanecarboxylate (OCE), 611-10-9, Sodium Loxoprofen Intermediate